摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

ethyl 3-(dimethylamino)-1-(4'-methylphenyl)-prop-2-enone-2-carboxylate | 76344-77-9

中文名称
——
中文别名
——
英文名称
ethyl 3-(dimethylamino)-1-(4'-methylphenyl)-prop-2-enone-2-carboxylate
英文别名
ethyl 1-(4'-methylphenyl)-3-(dimethylamino)prop-2-enone-2-carboxylate;3-dimethylamino-2-(4-methyl-benzoyl)-acrylic acid ethyl ester;ethyl 3-(dimethylamino)-2-(4-methylbenzoyl)prop-2-enoate
ethyl 3-(dimethylamino)-1-(4'-methylphenyl)-prop-2-enone-2-carboxylate化学式
CAS
76344-77-9
化学式
C15H19NO3
mdl
——
分子量
261.321
InChiKey
RRCBCGPTBNSMKE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    138-143 °C(Press: 3 Torr)
  • 密度:
    1.086±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.8
  • 重原子数:
    19
  • 可旋转键数:
    6
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    46.6
  • 氢给体数:
    0
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    ethyl 3-(dimethylamino)-1-(4'-methylphenyl)-prop-2-enone-2-carboxylate 在 lithium aluminium tetrahydride 作用下, 以 四氢呋喃乙醇 为溶剂, 反应 26.0h, 生成
    参考文献:
    名称:
    4-Substituted 1,5-diarylpyrazole, analogues of celecoxib: synthesis and preliminary evaluation of biological properties
    摘要:
    A number of 5-aryl-1-[4-(methylsulfonyl)-phenyl]-1H-pyrazoles and 4-(5-aryl-1H-pyrazol-1-yl)benzenesulfonamides 3, 4, 5, 6, analogues of the COX-2 selective inhibitor celecoxib (celebrex), were synthesized. In order to verify the effects on the biological properties of certain substituents put on position 4 of the pyrazole nucleus, some of these compounds were screened in vivo for their anti-inflammatory and analgesic activities. Moreover, sodium salts of carboxylic acids 4 were tested in vitro for their platelet anti-aggregating properties. The results of these preliminary biological assays showed that new derivatives are not endowed with improved anti-inflammatory and analgesic properties, in comparison with celecoxib. In addition, docking studies were carried out on the most significative compounds to evaluate their interaction mode at the active site of both COX-1 and COX-2. Some remarks about the SAR of this class of COX-inhibitors are drown out.
    DOI:
    10.1016/s0014-827x(03)00136-8
  • 作为产物:
    描述:
    对甲基苯甲酸乙酯 在 sodium hydride 作用下, 以 为溶剂, 反应 5.0h, 生成 ethyl 3-(dimethylamino)-1-(4'-methylphenyl)-prop-2-enone-2-carboxylate
    参考文献:
    名称:
    4-Substituted 1,5-diarylpyrazole, analogues of celecoxib: synthesis and preliminary evaluation of biological properties
    摘要:
    A number of 5-aryl-1-[4-(methylsulfonyl)-phenyl]-1H-pyrazoles and 4-(5-aryl-1H-pyrazol-1-yl)benzenesulfonamides 3, 4, 5, 6, analogues of the COX-2 selective inhibitor celecoxib (celebrex), were synthesized. In order to verify the effects on the biological properties of certain substituents put on position 4 of the pyrazole nucleus, some of these compounds were screened in vivo for their anti-inflammatory and analgesic activities. Moreover, sodium salts of carboxylic acids 4 were tested in vitro for their platelet anti-aggregating properties. The results of these preliminary biological assays showed that new derivatives are not endowed with improved anti-inflammatory and analgesic properties, in comparison with celecoxib. In addition, docking studies were carried out on the most significative compounds to evaluate their interaction mode at the active site of both COX-1 and COX-2. Some remarks about the SAR of this class of COX-inhibitors are drown out.
    DOI:
    10.1016/s0014-827x(03)00136-8
点击查看最新优质反应信息

文献信息

  • PYRIMIDINE COMPOUNDS AS SEROTONIN RECEPTOR MODULATORS
    申请人:Dvorak A. Curt
    公开号:US20070032481A1
    公开(公告)日:2007-02-08
    Certain pyrimidine-containing compounds are serotonin receptor modulators useful in the treatment of serotonin-mediated diseases.
    某些含嘧啶的化合物是有效的血清素受体调节剂,可用于治疗血清素介导的疾病。
  • Synthesis and Cytotoxicity of Substituted Ethyl 2-Phenacyl-3-phenylpyrrole-4-carboxylates
    作者:Michael A. Evans、Daniel C. Smith、Justin M. Holub、Anthony Argenti、Mafoloe Hoff、Gerard A. Dalglish、Donna L. Wilson、Brett M. Taylor、Joshua D. Berkowitz、Bruce S. Burnham、Keith Krumpe、John T. Gupton、Tanya C. Scarlett、Richard W. Durham, Jr、Iris H. Hall
    DOI:10.1002/ardp.200390018
    日期:2003.6
    The substituted ethyl‐2‐phenacyl‐3‐phenylpyrrole‐4‐carboxylates were synthesized by a condensation of a beta‐chloroenal and an alpha‐aminoketone under neutral conditions. They proved to be potent cytotoxic agents against the growth of murine L1210 and P388 leukemias and human HL‐60 promyelocytic leukemia, HuT‐78 lymphoma, and HeLa‐S3 uterine carcinoma. Selective compounds were active against the growth
    取代的乙基-2-苯甲酰基-3-苯基吡咯-4-羧酸酯是通过β-氯烯醛和α-氨基酮在中性条件下缩合合成的。它们被证明是针对鼠 L1210 和 P388 白血病以及人 HL-60 早幼粒细胞白血病、HuT-78 淋巴瘤和 HeLa-S3 子宫癌生长的有效细胞毒剂。选择性化合物对 Tmolt3 和 Tmolt4 白血病和 THP-1 急性单核细胞白血病、肝 Hepe-2、卵巢 1-A9、回肠 HCT-8 腺癌和骨肉瘤 HSO 的生长具有活性。HL-60 细胞的作用模式研究表明,DNA 和蛋白质合成在 100 [TH] μM 下 60 [TH] 分钟后受到抑制。DNA 和 RNA 聚合酶、PRPP-酰胺基转移酶、二氢叶酸还原酶、胸苷酸合酶、和 TMP 激酶活性受到试剂的干扰,d [NTP] 池减少。与 DNA 碱基的非特异性相互作用和 DNA 的交联可能在这些羧酸盐的作用模式中起作用。
  • Rational design, synthesis and biological evaluation of new 1,5-diarylpyrazole derivatives as CB1 receptor antagonists, structurally related to rimonabant
    作者:Giulia Menozzi、Paola Fossa、Elena Cichero、Andrea Spallarossa、Angelo Ranise、Luisa Mosti
    DOI:10.1016/j.ejmech.2008.01.043
    日期:2008.12
    4-dichlorophenyl)-5-arylpyrazoles strictly related to rimonabant, but with the hydrazide/amide group shifted from position 3 to position 4 of the pyrazole scaffold. The synthesized compounds were evaluated in vitro for their affinity on human CB(1) and CB(2) (cannabinoid type-2) receptors. Computational studies, performed both in the design step and after biological assays, contributed to rationalize the obtained
    在1型大麻素(CB(1))受体拮抗剂中,围绕利莫那班(Acomplia)的1,5-二芳基吡唑骨架开发的那些拮抗剂(对Acomplia进行了最广泛的研究。近年来,有关该主题的许多SAR和QSAR报告已经发表,着眼于N1和C5芳基官能团的取代和取向以及3-羧酰胺位置的取代基在这种情况下,我们的研究目的是设计和合成一组1-(2,4-二氯苯基) -5-芳基吡唑与利莫那班严格相关,但酰肼/酰胺基团从吡唑支架的3位转移到4位。合成后的化合物在体外对人CB(1)和CB(2)的亲和力进行了评估(大麻素2型受体)在设计步骤和生物学分析后均进行了计算研究,在拮抗剂和人类CB(1)受体之间的特定分子相互作用方面,有助于合理化所获得的结果。
  • Pyrimidine compounds as serotonin receptor modulators
    申请人:Janssen Pharmaceutica NV
    公开号:US07598255B2
    公开(公告)日:2009-10-06
    Certain pyrimidine-containing compounds are serotonin receptor modulators useful in the treatment of serotonin-mediated diseases.
    某些含嘧啶的化合物是血清素受体调节剂,可用于治疗与血清素相关的疾病。
  • Holub, Justin M.; O'Toole-Colin, Kathy; Getzel, Adam, Molecules, 2004, vol. 9, # 3, p. 135 - 157
    作者:Holub, Justin M.、O'Toole-Colin, Kathy、Getzel, Adam、Argenti, Anthony、Evans, Michael A.、Smith, Daniel C.、Dalglish, Gerard A.、Rifat, Shahzad、Wilson, Donna L.、Taylor, Brett M.、Miott, Ulander、et al.
    DOI:——
    日期:——
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐